Non-linear modifications enhance prediction of pathological response to pre-operative PD-1 blockade in lung cancer: A longitudinal hybrid radiological model

• Main Authors: Weiqiu Jin (Author), Yu Tian (Author), Wendi Xuzhang (Author), Hongda Zhu (Author), Ningyuan Zou (Author), Leilei Shen (Author), Changzi Dong (Author), Qisheng Yang (Author), Long Jiang (Author), Jia Huang (Author), Zheng Yuan (Author), Xiaodan Ye (Author), Qingquan Luo (Author)
• Format: Book
• Published: Elsevier, 2023-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Major pathologic remission (MPR, residual tumor <10%) is a promising clinical endpoint for prognosis analysis in patients with lung cancer receiving pre-operative PD-1 blockade therapy. Most of the current biomarkers for predicting MPR such as PD-L1 and tumor mutation burden (TMB) need to be obta...